Infecciones del área quirúrgica

1. Mangram AJ, Horan TC, Pearson ML, et al. Centers for Disease Control and Prevention guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999; 20:247–78.
2. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13(10):606–8.
3. National Institute for Health and Clinical Excellence. Clinical guideline: surgical site infection prevention and treatment. Available at: http://www.nice.org.uk/cg74. Accessed December 28, 2012.
4. Reilly J, Cairns S, Fleming S, et al. Results from the second Scottish national prevalence survey: the changing epidemiology of healthcare-associated infection in Scotland. J Hosp Infect 2012; 82(3):170–4.
5. de Lissovoy G, Fraeman K, Hutchins V, et al. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009; 37:387–97.
6. Gravel D, Taylor G, Ofner M, et al. Point prevalence survey for health care associated infections within Canadian adult acute-care hospitals. J Hosp Infect 2007; 66(3):243–8.
7. Magill SS, Hellinger W, Cohen J, et al. Prevalence of health-care associated infections in acute care hospitals in Jacksonville, Florida. Infect Control Hosp Epidemiol 2012; 33(3):283–91.
8. Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20(11):725–30.
9. Hidron AI, Edwards JR, Patel J, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29(11): 996–1011.
10. Pan A, Lee A, Cooper B, et al. Risk factors for previously unknown methicillin resistant Staphylococcus aureus carriage on admission to 13 surgical wards in Europe. J Hosp Infect 2013; 83(2):107–13.
11. Harbarth S, Sax H, Uckay I, et al. A predictive model for identifying surgical patients at risk of methicillin-resistant Staphylococcus aureus carriage on admission. J Am Coll Surg 2008; 207(5):683–9.
12. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013; 14(1):73–156.
13. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 2010; 11:79–109.
14. Richards JE, Kauffmann RM, Zuckerman SL, et al. Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery. J Bone Joint Surg Am 2012;94(13): 1181–6.
15. Jackson RS, Amdur RL, White JC, et al. Hyperglycemia is associated with increased risk of morbidity and mortality after colectomy for cancer. J Am Coll Surg 2012; 214(1):68–80.
16. Ata A, Lee J, Bestle SL, et al. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg 2010; 145(9):858–64.
17. Kavanagh BP, McCowen KC. Clinical practice. Glycemic control in the ICU. N Engl J Med 2010; 363(26):2540–6.
18. Hirsch IB. Understanding low sugar from NICE-SUGAR. N Engl J Med 2012;367(12):1150–2.
19. NICE-SUGAR Study Investigators, Finfer S, Liu B, et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367(12):1108–18.
20. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109(12):1497–502.
21. Leibowitz G, Raizman E, Brezis M, et al. Effects of moderate intensity glycemic control after cardiac surgery. Ann Thorac Surg 2010; 90(6):1825–32.
22. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32:1119–31.
23. Lazar HL, McDonnell MM, Chipkin S, et al. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Ann Surg 2011; 254:458–64.
24. Venturi ML, Attinger CE, Mesbahi AN, et al. Mechanisms and clinical applications of the vacuum-assisted closure (VAC) device: a review. Am J Clin Dermatol 2005;6:185–94.
25. Shuman EK, Urquhart A, Malani PN. Management and prevention of prosthetic joint infection. Infect Dis Clin North Am 2012; 26:29–39.
26. Young MH, Upchurch GR, Malani PN. Vascular graft infections. Prosthetic joint infection. Infect Dis Clin North Am 2012; 26:41–56.
27. Townsend CM, Beauchamp RD, Evers BM, et al. Sabiston textbook of surgery. 19th edition. Missouri: Elsevier; 2012.